Tran Dat Q
Division of Pediatric Research Center, Department of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, USA.
Methods Mol Biol. 2013;979:199-212. doi: 10.1007/978-1-62703-290-2_16.
FOXP3(+) regulatory T cells (Tregs) play an important role in controlling immune activation, maintenance of -homeostasis and the prevention of autoimmunity. Much effort has been focused in assessing their potential defects in certain human diseases and in developing potential Treg immunotherapy to cure autoimmune conditions. One cardinal feature of Tregs is their ability to suppress the activation and proliferation of effector T cells. The in vitro suppression assay is a convenient and relatively reliable method to quantify their suppressive function and validate their identity as true Tregs. This protocol describes a reliable, nonradioactive in vitro suppression assay to assess the immunosuppressive property of human Tregs in inhibiting proliferation of dye-labeled responder T cells using non-irradiated, HLA-DR(+) antigen presenting cells and soluble anti-CD3 antibodies as stimuli.
FOXP3(+)调节性T细胞(Tregs)在控制免疫激活、维持体内平衡以及预防自身免疫方面发挥着重要作用。人们已投入大量精力评估它们在某些人类疾病中的潜在缺陷,并开发潜在的Treg免疫疗法来治疗自身免疫性疾病。Tregs的一个主要特征是它们能够抑制效应T细胞的激活和增殖。体外抑制试验是一种方便且相对可靠的方法,用于量化它们的抑制功能并验证其作为真正Tregs的身份。本方案描述了一种可靠的非放射性体外抑制试验,以评估人Tregs在使用未辐照的HLA-DR(+)抗原呈递细胞和可溶性抗CD3抗体作为刺激物时,抑制染料标记的反应性T细胞增殖的免疫抑制特性。